NPR’s article, “A new chapter for online sales of obesity drug alternatives tests legal limits” focu...
Compounded medications save lives. They fill critical gaps when commercial drugs are unavailable or ...
The New York Times considered how the official end of the GLP-1 shortages is affecting patients — yo...
“The GLP-1 drug shortage is over. What’s next for the compounders?” asks Pharmaceutical Technology m...
Inside Health Policy covered our letter to FDA protesting the agency's recent (ridiculous) statement...